Animal Health
Cargill Meat Solutions, Wichita
The KBA awarded $750,000 over five years to Cargill Meat Solutions of Wichita to support the construction of a state-of-the-art technology and innovation center focused on food safety and the development of new food products, pending a decision by the company to build the planned research facility in Kansas. Cargill Meat Solutions would make a capital investment of $15 million in the expansion, retain 51 jobs, and hire an estimated 10 new employees. Parent company Cargill employs more than 1,000 people in Wichita and is the city’s largest private sector employer.
(5/10/2010).
Expected or Realized Outcomes: $15 million capital investment, retention of 51 jobs in Kansas and addition of estimated 10 net new jobs at an average salary of $73,600 over five years
KSU Arthropod-Borne Animal Diseases Research Unit (ABADRU), Manhattan
The KBA awarded $498,917 to the U.S. Department of Agriculture’s Arthropod-Borne Animal Diseases Research Unit (ABADRU) in Manhattan from the KBA’s Collaborative Biosecurity Research Initiative to accelerate the development of diagnostic tests intended to prevent the spread of Rift Valley Fever virus, a high consequence biological threat to the food supply. The project is a collaboration of ABADRU, Kansas State University, the University of Wyoming and MKS Technologies.
(5/10/2010).
Expected or Realized Outcomes: The commercialization potential from this research exists primarily in providing
diagnostics reagents and point of care tools to regional BSL-2 laboratories for early detection of RVF. As Kansas prepares for NBAF’s implementation, this will likely bring more collaborations, companies, research and jobs to Kansas.
Ceva Biomune, Lenexa
The KBA awarded $700,000 to Lenexa-based Ceva Biomune to expand its manufacturing facility for the production of vaccines for the global poultry market. The company intends to create 81 new bioscience jobs and invest approximately $15 million in the expansion.
(3/9/2010).
Expected or Realized Outcomes: 81 new full time bioscience jobs in Kansas with average salary of $50,000, and investment of approximately $15 million in facility build-out, equipment, and renovations to expand its manufacturing capacity
Kansas State University, Manhattan
The KBA awarded $500,000 from the KBA’s Collaborative Biosecurity Research Initiative to a research team led by Kansas State University’s Dr. Jishu Shi, to develop novel vaccines to combat a serious viral disease threatening swine and swine production globally. The researchers will focus on the host immune response that protects some pigs from multiple strains of the disease, with particular focus on a super virulent Asian strain of the virus.
(1/26/2010).
Expected or Realized Outcomes: Potential new company and establish international cooperation and collaboration
City of Manhattan, Manhattan
The KBA awarded $1 million to the city of Manhattan, Kan., to complete the build out of space in the city’s wet-lab incubator park. The city will invest $425,000 in the build out, in addition to the $5.65 million it has invested in the park to date.
(8/14/2009).
Expected or Realized Outcomes: Attraction of companies; $425,000 in capital expenditures
Megastarter, Wamego
The KBA awarded $300,000 to Megastarter, LLC, pending the company’s relocation from Colorado to Kansas to develop and commercialize a microbial supplement for the livestock and dairy industry. The supplement will provide agricultural producers with a low-cost method to improve animal health and substantially increase profitability by counteracting and preventing rumen acidosis, a destructive digestive condition in cattle caused by the build-up of lactic acid.
(8/14/2009).
Expected or Realized Outcomes: An industrial attraction that could lead to a full-scale production company and 13 new jobs. As the company scales up, it may require a larger production facility to provide this product, and potentially others, to the global marketplace, resulting in additional capital expenditure and job growth.
ANOxA CORP, Kansas
The KBA awarded $300,000 to ANOxA CORP, an animal-health biotechnology company, for the commercialization of a new drug to treat a common equine disorder should it move its headquarters to Kansas. The company is expected to hire seven employees upon relocation.
(10/28/2008).
Expected or Realized Outcomes: Seven new employees, relocation to Kansas, and $6 million in equity financing.
Biosecurity Research Institute Training and Education Enhancement, Manhattan, Kansas
The KBA awarded $1,548,000 to implement technologies at the Biosecurity Research Institute (BRI) at Kansas State University and enhance the ability to offer distance educational programming via satellite or over the Internet. The BRI’s integrated training suite (ITS) is a combined modern classroom and fully functional laboratory with all the equipment common to a biosafety level 3 research laboratory. With additional technologies, the ITS will become a functioning educational studio permitting the BRI learning experience to include the production of professional-level DVDs of training programs. The BRI training and education DVDs will be offered for national and international distribution, further demonstrating leadership in this arena and greatly extending the impact of K-State. This leadership in biosecurity education and training will serve as a national resource for training the staff that will occupy the proposed National Bio and Agro-Defense Facility.
(2/26/2008).
Expected or Realized Outcomes: Enhance the BRI as an attractor for the NBAF, for new bio-businesses, and additional research programs for the BRI. At just 27 percent occupancy, the ITS could generate $564,300 per year in revenue, and, with training and education programs in the lecture hall at a 57 percent occupancy rate, there is a potential to generate $945,000 per year in funding.
Kansas State University Eminent Scholar, Manhattan, Kansas
The KBA awarded up to $2,055,000 over five years to establish Dr. Juergen Richt (DVM, PhD) as a Regents distinguished professor at Kansas State University. Dr. Richt will have a primary faculty appointment in the Department of Diagnostic Medicine/Pathobiology, an academic unit of the College of Veterinary Medicine. He is expected to be a campus and statewide asset, providing animal health research leadership with investigators in the College of Veterinary Medicine, the university and the state. Dr. Richt’s infectious disease work requires a combination of BSL-3/BSL-3Ag biocontainment to be conducted in the Biosecurity Research Institute at K-State. He has been a lead scientist at the National Animal Disease Center (in the Virus and Prion Diseases of Livestock Research Unit) and a professor at Iowa State University. He is involved in cutting-edge research in two high-impact areas, prion diseases and influenza, and has established a strong reputation in the basic science of borna viruses and vaccines and diagnostics for other key viral diseases.
(1/16/2008).
Expected or Realized Outcomes: Approximately $4 million in research funding over five years.
Collaborative Biosecurity Research Initiative, Manhattan, Kansas
The KBA has launched a $2.5 million Collaborative Biosecurity Research Initiative (CBRI) to bring together researchers nationwide to create products that protect Americans from the intentional use of animal-borne diseases to disrupt the national economy or to infect humans. The goal of the CBRI is to support inter-institutional research to: 1) develop counter-measures for foreign-animal diseases; 2) provide advanced test and evaluation capability for threat detection, vulnerability, and countermeasure assessment for animal and zoonotic diseases; 3) support licensure of vaccine countermeasures through essential animal-model testing and evaluation; and 4) strengthen biosecurity capabilities of institutions serving certain regions and populations.
(9/28/2007).
Expected or Realized Outcomes: The CBRI will introduce the unique biosecurity research capabilities and facilities at Kansas State University to investigators nationally and develop strategic alliances to promptly confront animal- and public-health threats by leveraging multi-disciplinary expertise.
Fort Dodge Animal Health, Overland Park, Kansas
The KBA awarded $3.5 million and 30 acres of land in the Kansas Bioscience Park to Fort Dodge Animal Health for the expansion of its North American research and development laboratories in Olathe, Kansas.
(7/10/2007).
Expected or Realized Outcomes: 215 new employees and approximately $39 million in capital expenditures.
National Bio and Agro-Defense Facility, Manhattan, Kansas
The Department of Homeland Security is building a $650 million federal laboratory to research and develop countermeasures to animal, human, and zoonotic diseases. On the merits, Kansas was selected for this initiative to protect the American food supply and agriculture economy, and KBA funding supports the effort to bring the NBAF to Kansas.
(1/9/2007).
Expected or Realized Outcomes: $650 million in capital expenditures, approximately 1,500 jobs during construction, and 471 permanent jobs during operations.
IdentiGEN North America, Lawrence, Kansas
The KBA awarded $125,000 to IdentiGEN for a research voucher for a K-State professor and financial assistance to defray the cost of scientific equipment in Kansas laboratories. IdentiGEN is an innovative provider of DNA-based solutions to the agri-food industry with plans to locate headquarters for its U.S. operations in Lawrence.
(4/11/2006).
Expected or Realized Outcomes: Approximately 35 new employees, $41,500 in research funding, and $1.9 million in capital expenditures.